Show results for
transformational-science-and-technology Videos
5 videos found
xCures' AI-assisted platform automatically retrieves medical records from any institution where a cancer patient visited and organizes them into a powerful care summary. This summary greatly facilitates the generation of treatment options reports and connects cancer patients and their physicians with optimal approved or investigational therapies. Here is how it ...
Jan. 22, 2023
ByxCures
Clinisys interviewed Dr. John Sinard, Vice Chair and Director of Clinical Operations in Pathology at Yale University School of Medicine, to hear his experiencewith the reporting structure and organization for the anatomic pathology informatics team. Should the AP IT team be part of central IT? Should they be part of the laboratory medicine IT team? With responsibilities for the maintenance and ...
Oct. 5, 2023
In this interview, Clinisys asked Dr. John Sinard, Vice Chair and Director of Clinical Operations in Pathology at Yale University School of Medicine, to reflect on the benefits his own anatomic pathology team at Yale has experienced in justifying the expense of implementing a digital pathology program. Dr. Sinard cautioned that there are opportunities for individuals to overrepresent the ...
Oct. 5, 2023
Rachel talks about how xCures made her husband's medical records easy to understand. This helped her when talking to time-pressed oncologists to get treatment help for her husband who was diagnosed with cancer. --- ABOUT xCURES --- The xCures platform is a direct-to-patient and direct-to-physician portal that identifies the most promising treatment options for advanced cancer patients who are ...
Jan. 22, 2023
ByxCures
Oramed Pharmaceuticals (NASDAQ: ORMP) has developed an innovative technology to transform injectable treatments into oral therapies. The accompanying presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. For example, Oramed is using forward-looking statements when it discusses its clinical ...
Apr. 2, 2021